Dublin–(business wire)–“CRISPR Technology Market by Product, Application, End-User and Region – Size, Share, Outlook and Opportunity Analysis, 2022-2028” report added of ResearchAndMarkets.com Recruitment.

CRISPR technology is driving advances in genome editing in medicine, pharmaceuticals, biotechnology, and agriculture, enabling scientists around the world to conduct research in these areas through faster and more efficient genome editing. CRISPR is also used to correct genetic defects, treat human diseases, and produce better crop varieties.

It has many potential uses, including treating and preventing the spread of disease, correcting genetic defects, and improving crops. The CRISPR-Cas9 system has a wide range of applications. In medicine, it has applications in research into cancer, viral infections, genetic diseases, and pathogen detection. CRISPR is a technology that can be used for gene editing and has the potential to change the world.

Market dynamics:

The COVID-19 outbreak across the globe, increasing number of ongoing clinical trials, and expanding research into gene-editing tools are some of the factors expected to drive the growth of the global CRISPR technology market during the forecast period. A major factor. For example, in March 2020, a scientist at the University of Toronto developed his CHyMErA, his CRISPR-based tool for more versatile genome editing.

CRISPR technology has great potential for both prevention and control of COVID-19. In March 2020, researchers at the Genome Center in New York developed a new CRISPR screening technology that targets RNA, including that of a new virus (COVID-19). Additionally, in November 2019, researchers at his ETH Zurich in Switzerland replaced the CAS9 enzyme with CAS 12a. This allowed researchers to edit genes at her 25 target sites.

Key features of the survey:

  • This report provides an in-depth analysis of the global CRISPR technology market, with market size ($ million) and compound annual growth rate (CAGR %) over the forecast period (2022-2028), with 2021 as the base year. Offers.

  • It reveals potential revenue opportunities across various segments and describes an attractive investment proposition matrix for this market.

  • The study also provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.

  • Key players in the global CRISPR technology market are profiled based on parameters such as company highlights, product portfolios, key highlights, financial performance, and strategies.

  • Leading companies covered in this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), Danaher Corporation (Integrated DNA Technologies), etc.

  • Insights from this report will enable marketers and corporate management authorities to make informed decisions regarding future product launches, type upgrades, market expansions, and marketing strategies.

  • The Global CRISPR Technology Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants and financial analysts.

  • Stakeholders can facilitate their decision-making through various strategy matrices used in analyzing the global CRISPR technology market.

Detailed Segmentation: Global CRISPR Technology Market, By Product:

  • enzyme

  • Kits and reagents

  • Guide RNA

  • others

Global CRISPR Technology Market by Application:

  • biomedical

  • Agriculture

  • industrial

  • others

Global CRISPR Technology Market, By End User:

  • Pharmaceutical and biotech companies

  • Academic and Government Research Institutes

  • Others (CRO, etc.)

Global CRISPR Technology Market, By Region:

  • North America

  • Europe

  • Asia Pacific

  • Middle East and Africa

  • South America

Main topics:

1. Purpose and premises of the research

2. Market scope

3. Market dynamics, regulation and trend analysis

  • market dynamics

  • Growing Demand and Adoption of CRISPR

  • High cost of CRISPR

  • COVID-19 (global pandemic) outbreak

  • impact analysis

  • major highlights

  • Regulatory scenario

  • Product Launch/Approval

  • PEST analysis

  • Analysis of PORTER

  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market – Impact of Coronavirus (COVID-19) Pandemic

5. Global CRISPR Technology Market, by Product, 2017-2028, (US$ Mn)

6. Global CRISPR Technology Market, Applications, 2017-2028, (US$ Mn)

7. Global CRISPR Technology Market, By End User, 2017-2028, (USD Million)

8. Global CRISPR Technology Market, by Region, 2017-2028, (US$ Mn)

9. Competitive environment

10. Section

companies mentioned

  • Merck KGaA

  • thermo fisher scientific

  • Origen Technologies Co., Ltd.

  • new england bio lab

  • gen script

  • Gene Copoeia Co., Ltd.

  • Selector Co., Ltd.

  • Agilent Technologies, Inc.

  • perkin elmer

  • Co., Ltd. (Horizon Discovery Co., Ltd.)

  • Danaher Corporation (Integrated DNA Technology)

For more information on this report, please visit https://www.researchandmarkets.com/r/r0cc33.


Source link


Submit a Comment

Your email address will not be published. Required fields are marked *